4.1 Article

Radio labelling of peptides for PET, SPECT and therapeutic applications using a fully automated disposable cassette system

期刊

NUCLEAR MEDICINE COMMUNICATIONS
卷 32, 期 10, 页码 887-895

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MNM.0b013e3283497188

关键词

automation; diagnostics and therapy; radiolabelled peptides; radiopharmaceuticals

资金

  1. Bundesministerium fur Wirtschaft und Technologie of Germany [KF2500801FR9]

向作者/读者索取更多资源

Objectives Radio labelled somatostatin analogues have found wide clinical use in nuclear medicine for both diagnostic and therapeutic applications. Here, we describe the development of a fully automated synthesis system allowing radiolabelling of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-derivatized peptides with Ga-68/In-111/Lu-177 and Y-90, meeting radiation safety and. pharmaceutical requirements. Materials and methods The system consists of a syringe pump, a holder for insertion of a single use multivalve cassette, a heater and a removable radiation shielding. Ga-68 labelling was performed in acetate buffer and Lu-177, Y-90 and In-111 labelling in ascorbate buffer, respectively, followed by purification on a C18 cartridge and final sterile filtration. Cross-contamination was prevented by using disposable cassettes and also by ensuring pharmaceutical standards. Radiochemical purity (RCP) was determined by instant thin-layer chromatography on silica gel impregnated glass fibres and reversed-phase high performance liquid chromatography. Results Ga-68-DOTA-peptides were prepared with high RCP (>91%) and radiochemical yields (RCY >80% decay corrected) and Ge-68 content was less than 0.0001% in all cases. Synthesis time did not exceed 30 min. In-111, Lu-177 and Y-90 labelling of DOTA-peptides resulted again in high yields (approximately 90%) and RCP (approximately 95%) and total synthesis time of less than 45 min. Radiation dose to fingers was considerably reduced when compared with manual labelling procedures. Conclusion The described system allows fully automated, aseptic preparation of DOTA-peptides radiolabelled with different radionuclides in high radiochemical yields and pharmaceutical quality suitable for clinical application. Nucl Med Commun 32:887-895 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins. Nuclear Medicine Communications 2011, 32:887-895

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据